Keyword: Catalent


Catalent Starts Schorndorf Expansion

13.04.2023 -

Catalent, a US-headquartered CDMO, has broken ground on a project in Schorndorf, Germany, that will add capacity for storing and handling clinical trial supply materials...


Catalent Opens Cell Therapy Facility in Belgium

13.12.2022 -

Catalent has opened a new commercial-scale cell therapy manufacturing facility at its European center of excellence for cell therapies in Gosselies, Belgium.


Catalent Completes Shanghai Plant Expansion

06.12.2022 -

US-headquartered CDMO giant Catalent has completed the expansion of its clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.


Catalent to Invest $12 Million at Kansas City

26.10.2022 -

Catalent has announced a $12 million expansion program to increase biologics CGMP analytical capabilities at its flagship facility in Kansas City, Missouri.


Catalent to Buy Metrics Contract Services

12.08.2022 -

CDMO heavyweight Catalent is acquiring compatriot Metrics Contract Services, a full-service specialty CDMO with a facility in Greenville, North Carolina, for $475 million...


Catalent to Invest $350 Million at Bloomington HQ

22.04.2022 -

Catalent has announced it will spend $350 million over several years to expand biologics drug substance and drug product manufacturing capabilities at its Bloomington...

Markets & Companies

Ramping Up Biomanufacturing Capacity

20.04.2022 -

Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of...


Catalent to Invest in UK Biologics Capabilities

13.04.2022 -

Catalent has acquired a 174,000 m2 biologics development and manufacturing facility currently being built by Vaccine Manufacturing and Innovation Centre UK (VMIC) on the...